News

Lallemand, An Active Member of The Grand Défi Ferments Du Futur Consortium: Innovating For the Food of Tomorrow

Read

Sylvie Binda elected on the Pharmabiotic Research Institute board of directors

Read

Lallemand Health Solutions Appoints Vincent Thomas, Ph.D. as R&D Innovation Director

Read

Lallemand Health Solutions supports the innovative French Gut Project to accelerate microbiota science

Read

Lallemand Health Solutions Opens the SEMiPyP Congress With An Update on IBacilluS+: A Highly Documented Probiotic Formula for Serious Gut Conditions

Read

Having IMPACTT 2022: The Rosell® Institute for Microbiome and Probiotics Renews Its Platinum Sponsorship

Read

Lallemand Health Solutions at Pharmabiotics: Join in To Learn More About Discovery, Development & Preclinical Research

Read

Lallemand Health Solutions There to Support the Emerging Science of The Microbiota

Read

Sylvie Binda, Vice-President R&D of Lallemand Health Solutions Appointed Vice-President of The New Office of The Alliance Promotion Microbiote

Read

Microbiome and ALS: a $1.6 million grant for research

Read